As Larry Husten of CardioBrief reports, Erasmus MC’s investigation included that Poldermans — perhaps best known for his work on beta-blockers — has admitted to acts of misconduct but not to fraud.
That’s not merely a distinction without a difference. Poldermans, for instance, claims that the suspect gaps in his data records, which Erasmus MC calls “serious shortcomings” in fact reflect losses due to water damage and files the university itself trashed.
We may never know the truth here, but one thing on which both sides agree is that no patients were harmed by the misconduct.
It seems unusual to us, given the findings — perhaps worthy of our own Expression of Concern? — that none of Poldermans’ studies seem to have been retracted, nor even subject to Expressions of Concern. As we noted at in an earlier post: